Ivan Poullaos

Practice Areas

Ivan Poullaos is an accomplished patent trial lawyer. He has developed a particular concentration in pharmaceutical Hatch-Waxman and biologics infringement cases. With a degree in chemistry, Ivan is able to take many technical cases to trial with remarkable success. His trial wins in the pharmaceutical sector have been notable. He previously obtained a significant jury trial victory in a case in which our client’s generic Suboxone® and Subutex® tablets were cleared from allegations of patent infringement. As a result of the jury’s favorable finding, the jury awarded no damages against our client, despite a request for more than US$40 million. 

Ivan achieved another notable trial win, convincing the court to invalidate the patent covering the active ingredient molecule in the Hepatitis B treatment, Baraclude® (entecavir). The decision was especially important because for the first time, it invalidated as “obvious” a patent on a new chemical compound. The case received extensive press coverage, including articles in Forbes, Bloomberg, Law360, Inside Counsel, and countless IP, FDA, and patent law-related blogs. Ivan also represented this client in the appellate stage of the case, where the district court’s ruling was affirmed.

Well before trial, Ivan's clients look to his strategic advice and analysis to determine the best and most efficient way to achieve their goals, including the potential use of proceedings before the Patent Office.